Affiliation:
1. Department of Nuclear Medicine and Molecular Diagnostics, Neumod, Hubli, Karnataka, India,
Abstract
Prostate cancer (PCa) is one of the most frequent cancers in men and constitutes the third most common cause of cancer deaths. Early diagnosis of primary PCa, accurate staging, as well as accurate restaging in the case of cancer recurrence after primary treatment are important for delivering the appropriate therapy. In the past 10 years, functional and molecular imaging by means of positron emission tomography/computed tomography (PET/CT) and PET/magnetic resonance are increasingly being used for such indications. This article provides a radiolabelled tracer-based review of the diagnostic value of PET/CT in primary and recurrent PCa.